More than 99.99% of fully vaccinated people have not had a severe breakthrough case of Covid-19

More than 99.99% of fully vaccinated people have not had a severe breakthrough case of Covid-19
More than 99.99% of fully vaccinated people have not had a severe breakthrough case of Covid-19

The idea that the entire world is being vaccinated against the ‘very rare’ (in the U.S.) disease called Covid-19 has been circulating for a while now, but the newest iteration of the myth is more ridiculous than ever.  This is according to a recent report on the subject by the National Vaccine Information Center (NVIC), a non-profit organization dedicated to promoting safe vaccines and fighting for parental and public vaccine rights.  The report examined the justifications for the claim, and compiled statistics from countries whose vaccination rates actually do track the claimed “99.99%.”

In the middle of last year, scientists at the University of Oxford released the findings of a research study that found a risk of disease during a vaccination was much lower than was claimed. The study showed that even for a vaccinated person, the risk of serious health complications, such as the contracting of a crippling disease, was only 1 in 20,000 – and that risk dropped as the number of vaccinations increased. The research showed that, even among people who had received several vaccinations, the risk of getting a serious illness was no higher than 1 in a million, and had been decreasing in the last 30 years, as vaccination rates increased. The Oxford study is thought to be the most comprehensive and rigorous examination of vaccination risks ever conducted.


Infections caused by the Lambda variety have started appearing in the United States as the coronavirus pandemic continues, notably in Texas, where Houston Methodist Hospital reported its first case last month.

There’s still a lot we don’t know about Lambda, but here’s what we do know:

The variation is not nearly as dangerous as the Delta version in the United States, which has been driving an increase in cases throughout the country, but early investigations indicate that it contains changes that make it more transmissible than the original coronavirus strain.

Dr. Preeti Malani, chief health officer in the division of infectious diseases at the University of Michigan in Ann Arbor, said in an email on Friday, “Lambda contains mutations that are worrisome, but this variation remains very uncommon in the US despite being present for many months.”

We don’t know how contagious it is: “It’s impossible to tell for sure how contagious Lambda is and how effectively vaccinations function.” According to Malani, a specialist with the Infectious Diseases Society of America, Lambda seems to be more transmissible than the original SARS-CoV-2 virus, which is comparable to Delta and other variations. The coronavirus that causes Covid-19 is known as SARS-CoV-2.

“Fortunately, research show that the presently available vaccinations are still effective. As we saw during the pandemic, things may change fast, so limiting the spread of COVID-19 in general will aid in the management of Lambda,” Malani stated. “As long as SARS-CoV-2 spreads unchecked, we will see additional variations in the future.” To limit the spread of SARS-CoV-2 and prevent further mutation, mass immunization is the only option. It’s a race to get enough people vaccinated while also developing new strains that are less resistant to countermeasures.”

Concerning vaccinations, evidence on how effectively vaccines protect against the Lambda form is still mixed, and experts believe more research is needed.

In July, researchers wrote in a lab study that they found some evidence that people who got the single-dose Johnson & Johnson Covid-19 vaccine might benefit from a booster dose to better protect them from new variants of the coronavirus, including the Lambda variant. The study was done in the lab and does not reflect real-world effects of the vaccine – and it’s published online as a preprint to the server, meaning it was not subject to careful peer review.

Nathaniel Landau of the New York University Grossman School of Medicine and colleagues said their tests of blood taken from vaccinated volunteers shows that at least some of the newly emerging variants may evade the protection offered by a single dose of Johnson & Johnson’s Janssen vaccine. A boost of a second dose of J&J vaccine, or even with Moderna’s or Pfizer’s, might help, the researchers reported.

The variations Beta, Delta, Delta plus, and Lambda only exhibited “modest” resistance to antibodies induced by the Pfizer/BioNTech and Moderna coronavirus vaccines in the research, indicating that the vaccinations are still effective.

This article broadly covered the following related topics:

  • how many people are getting covid after vaccine?
  • what is the rate of breakthrough covid cases?
  • how likely are you to get covid if you are fully vaccinated?
  • why did i get covid after being fully vaccinated?
  • 99.99% 10
You May Also Like